Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$5.21 USD
+0.05 (0.97%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $5.22 +0.01 (0.19%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.57 |
Last EPS Surprise | 27.85% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.05 |
Next Year | -1.61 |
EPS (TTM) | -2.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.53M | 7.68M | 37.70M | 43.32M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 9.00M | 9.00M | 45.00M | 60.00M |
Low Estimate | 6.06M | 6.36M | 26.11M | 26.63M |
Year ago Sales | 5.31M | 5.60M | 34.15M | 37.70M |
Year over Year Growth Est. | 41.81% | 37.14% | 10.39% | 14.88% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.58 | -2.05 | -1.61 |
# of Estimates | 3 | 2 | 3 | 4 |
Most Recent Consensus | -0.59 | -0.62 | -2.53 | -2.18 |
High Estimate | -0.51 | -0.53 | -1.80 | -1.33 |
Low Estimate | -0.59 | -0.62 | -2.53 | -2.18 |
Year ago EPS | -0.73 | -0.70 | -2.34 | -2.05 |
Year over Year Growth Est. | 24.66% | 17.14% | 12.39% | 21.87% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.58 | -2.05 | -1.61 |
7 Days Ago | -0.55 | -0.58 | -2.05 | -1.61 |
30 Days Ago | -0.55 | -0.58 | -2.05 | -1.61 |
60 Days Ago | -0.68 | -0.70 | -2.40 | -1.98 |
90 Days Ago | -0.68 | -0.70 | -2.40 | -1.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.58 | -2.05 | -1.61 |
Zacks Consensus Estimate | -0.55 | -0.58 | -2.05 | -1.61 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.57 | -0.34 | -0.70 | -0.73 | NA |
Estimate | -0.79 | -0.72 | -0.73 | -0.68 | NA |
Difference | 0.22 | 0.38 | 0.03 | -0.05 | 0.15 |
Surprise | 27.85% | 52.78% | 4.11% | -7.35% | 19.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more